Jazz Pharmaceuticals plc (JAZZ)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity | Share change | % change to portfolio ▼ | |
| Q2 2024 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 52.84% | 440,552 | 1.33 | |
| Q1 2024 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 4,187 | 0.01 | |
| Q4 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 23.75% | 160,000 | 0.43 | |
| Q2 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 40.74% | 195,000 | 0.44 | |
| Q1 2023 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 478,696 | 1.25 | |
| Q2 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 39.55% | 7,329 | 0.01 | |
| Q1 2021 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 104.76% | 9,480 | 0.02 | |
| Q4 2020 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 9,049 | 0.02 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.